Mechanisms of action of isoniazidTIMMINS, Graham S; DERETIC, Vojo.Molecular microbiology (Print). 2006, Vol 62, Num 5, pp 1220-1227, issn 0950-382X, 8 p.Article

Study of the interaction between rifapentine and isoniazid under acid conditionsPRASAD, Bhagwat; BHUTANI, Hemant; SINGH, Saranjit et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 4, pp 1438-1441, issn 0731-7085, 4 p.Article

Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?KINZIG-SCHIPPERS, Martina; TOMALIK-SCHARTE, Dorota; JETTER, Alexander et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 5, pp 1733-1738, issn 0066-4804, 6 p.Article

Flow injection chemiluminescence determination of isoniazid with electrogenerated hypochloriteJIACHU HUANG; CHENGXIAO ZHANG; ZHUJUN ZHANG et al.Fresenius' journal of analytical chemistry. 1999, Vol 363, Num 1, pp 126-128, issn 0937-0633Article

Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adultsHATHERILL, Mark; GELDENHUYS, Hendrik; PIENAAR, Bernadette et al.Vaccine. 2014, Vol 32, Num 31, pp 3982-3988, issn 0264-410X, 7 p.Article

Additive effects of isoniazid preventive therapy and HAARTGOLUB, Jonathan E; CHAISSON, Richard E; MARIONA, Neil A et al.AIDS (London). 2009, Vol 23, Num 11, pp 1446-1447, issn 0269-9370, 2 p.Article

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis InfectionSTERLING, Timothy R; VILLARINO, M. Elsa; WEIS, Stephen E et al.The New England journal of medicine. 2011, Vol 365, Num 23, pp 2155-2166, issn 0028-4793, 12 p.Article

An explanation for the physical instability of a marketed fixed dose combination (FDC) formulation containing isoniazid and ethambutol and proposed solutionsBHUTANI, Hemant; MARIAPPAN, T. T; SINGH, Saranjit et al.Drug development and industrial pharmacy. 2004, Vol 30, Num 6, pp 667-672, issn 0363-9045, 6 p.Article

Travail original connaissances actuelles sur le mécanisme d'action de l'isoniazide. Apport d'un modèle chimique d'activation = Action mechanism of antitubercular isoniazid and role of a nonenzymatic activation systemBERNADOU, J; NGUYEN, M; MEUNIER, B et al.Annales pharmaceutiques françaises. 2001, Vol 59, Num 5, pp 331-337, issn 0003-4509Article

A case of latent tuberculosis reactivation in a patient treated with ustekinumab without concomitant isoniazid chemoprophylaxis in the PEARL trialTSAI, T.-F; CHIU, H.-Y; SONG, M et al.British journal of dermatology (1951). 2013, Vol 168, Num 2, pp 444-446, issn 0007-0963, 3 p.Article

A Fresh Look at the Mechanism of Isoniazid-Induced HepatotoxicityMETUSHI, I. G; CAI, P; ZHU, X et al.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 6, pp 911-914, issn 0009-9236, 4 p.Article

Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosisANDO, Hiroki; KITAO, Tomoe; MIYOSHI-AKIYAMA, Tohru et al.Molecular microbiology (Print). 2011, Vol 79, Num 6, pp 1615-1628, issn 0950-382X, 14 p.Article

Isoniazid induces its own resistance in nonreplicating Mycobacterium tuberculosisSIDDIQI, Salman; TAKHAR, Param; BALDEVIANO, Christian et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 6, pp 2100-2104, issn 0066-4804, 5 p.Article

Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff baseHEARN, Michael J; CYNAMON, Michael H.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 2, pp 185-191, issn 0305-7453, 7 p.Article

Overestimation of rifampicin during colorimetric analysis of anti-tuberculosis products containing isoniazid due to formation of isonicotinyl hydrazoneMARIAPPAN, T. T; JINDAL, K. C; SINGH, Saranjit et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 36, Num 4, pp 905-908, issn 0731-7085, 4 p.Article

Efficacité de l'aspiration à l'aiguille au cours d'un cas d'hypertrophie paradoxale d'une lymphadénite tuberculeuse = Needle aspiration and local isoniazid instillation for the management of paradoxical hypertrophy of tubercuious iymphadenitisMEYBECK, A; JUST, N; NYUNGA, M et al.Revue des maladies respiratoires. 2003, Vol 20, Num 6, pp 973-977, issn 0761-8425, 5 p., CAH1Article

Chemiluminescence sensor for isoniazid with controlled-reagent-release technologyZHENGHUA SONG; JIHONG LÜ; TIEZHU ZHAO et al.Talanta (Oxford). 2001, Vol 53, Num 6, pp 1171-1177, issn 0039-9140Article

Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in SingaporeLEE, A. S. G; LIM, I. H. K; TANG, L. L. H et al.Antimicrobial agents and chemotherapy. 1999, Vol 43, Num 8, pp 2087-2089, issn 0066-4804Article

Why have trials of isoniazid preventive therapy among people with HIV infection not demonstrated an effect on mortality? Did close examination of the trees obscure our view of the wood?GRANT, Alison D; FIELDING, Katherine L; CHARALAMBOUS, Salome et al.AIDS (London). 2010, Vol 24, issn 0269-9370, S15-S18, SUP5Article

Clinical Characteristics and Treatment Outcomes of Patients with Isoniazid-Monoresistant TuberculosisCATTAMANCHI, Adithya; DANTES, Raymund B; METCAIFE, John Z et al.Clinical infectious diseases. 2009, Vol 48, Num 2, pp 179-185, issn 1058-4838, 7 p.Article

The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutolCOLANGELI, Roberto; HELB, Danica; SACCHETTINI, James C et al.Molecular microbiology (Print). 2005, Vol 55, Num 6, pp 1829-1840, issn 0950-382X, 12 p.Article

Pleuro-péricardite induite par l'isoniazide = Isoniazid-induced pleuro-pericarditisJOUNEAU, S; VOLATRON, A.-C; BRINCHAULT, G et al.Revue de pneumologie clinique (Paris). 2003, Vol 59, Num 6, pp 357-359, issn 0761-8417, 3 p.Article

Inhibitors of fatty acid synthesis as antimicrobial chemotherapeuticsHEATH, R. J; WHITE, S. W; ROCK, C. O et al.Applied microbiology and biotechnology. 2002, Vol 58, Num 6, pp 695-703, issn 0175-7598Article

Flow-injection system for automated dissolution testing of isoniazid tablets with chemiluminescence detectionBAOXIN LI; ZHUJUN ZHANG; WEI LIU et al.Talanta (Oxford). 2001, Vol 54, Num 4, pp 697-702, issn 0039-9140Article

Female sex and discontinuation of isoniazid due to adverse effects during the treatment of latent tuberculosisPETTIT, April C; BETHEL, James; HIRSCH-MOVERMAN, Yael et al.The Journal of infection. 2013, Vol 67, Num 5, pp 424-432, issn 0163-4453, 9 p.Article